加味秦艽鳖甲汤治疗2型糖尿病合并初治涂阳肺结核的临床疗效

doi:10.3969/j.issn.1006-6233.2017.12.048

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1389 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To observe the clinical efficacy of jiawei qinjiao biejia decoction in the treatment of type 2 diabetes mellitus combined with newly diagnosed smear-positive pulmonary tuberculosis. Methods: 300 patients with type 2 diabetes mellitus complicated with newly diagnosed smear-positive pulmonary tuberculosis were randomly divided into two groups. The control group was treated with conventional hypoglycemic and anti-tuberculosis drugs. The treatment group was treated on the basis of the control group jiawei qinjiao biejia decoction and aerosol inhalation treatment, 6 months after treatment to evaluate the clinical efficacy. Results: The levels of FBG, 2hPBG, HbA1c and cough, sputum, wheezing and pulmonary rales in the two groups were lower than those in the control group, the difference was statistically significant (P<0.05), and the treatment group was lower than the control group, the difference was statistically significant (P<0.05). The effective rate of wound healing, cure rate and cure rate were higher in the treatment group than in the control group, the difference was statistically significant (P<0.05). Conclusion: The combination of jiawei qinjiao biejia decoction in the treatment of type 2 diabetes mellitus combined with newly diagnosed smear-positive pulmonary tuberculosis can better control blood sugar, promote sputum negative, lesion absorption and empty closure, and improve cough, sputum, wheezing, lung rales and other clinical symptoms, improve clinical efficacy.

Key words： Jiawei qinjiao biejia decoction Type 2 diabetes mellitus Newly diagnosed smear positive pulmonary tuberculosis Clinical efficacy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2017.12.048 OR http://www.hbyxzzs.cn/EN/Y2017/V23/I12/2092

[1] 杨贵发.2型糖尿病合并肺结核患者治疗方案的选择与评估[J].临床肺科杂志,2012,17(7):1269~1270.
[2] Baker MA,Harries AD,Jeon CY,et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review[J].BMC Med,2011,9(81):1~15.
[3] 中华医学会结核病学分会.肺结核诊断和治疗指南[J].中华结核和呼吸杂志,2001,24(2):70~74.
[4] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中国糖尿病杂志,2014,22(8):2~42.
[5] 中华人民共和国卫生部.肺结核门诊诊疗规范(2012年版)[J].中国医学前沿杂志(电子版),2013,5(3):73~75.
[6] 武剑,舒薇,李世元,等.肺结核合并糖尿病流行现状及其危险因素研究进展[J].疾病监测与控制杂志,2015,9(2):93~94.
[7] 毛晓辉,王勃,曹思哲.糖尿病合并肺结核的流行病学及诊治现状[J].临床肺科杂志,2016,21(12):2300~2302.
[8] 聂安正,林志健,王雨,等.秦艽化学成分及药理作用研究进展[J].中草药,2017,48(3):597~608.
[9] 杨丹,都艳玲,赵楠,等.青蒿素及其衍生物的药理作用研究进展[J].吉林医药学院学报,2014,35(2):132~134.
[10] 李彬,郭力城.鳖甲的化学成分和药理作用研究概况[J].中医药信息,2009,26(1):25~27.
[11] 李红伟,孟祥乐.地黄化学成分和药理作用研究进展[J].药物评价研究,2015,38(2):218~228.
[12] 冯菲.知母的药理作用研究进展[J].中医临床研究,2017,9(12):133,137.
[13] 胡云飞,徐国兵.牡丹皮及其主要成分丹皮酚的药理作用研究进展[J].安徽医药,2014,18(4):589~592.
[14] 郑海群.地骨皮降血糖药理作用的研究进展[J].中国处方药,2016,14(3):13~14.
[15] 孙晓卉,张量.柴胡药理作用的研究进展[J].中国医药导报,2017,14(10):52~55.
[16] 张小琼,侯晓军,杨敏,等.乌梅的药理作用研究[J].中国药房,2016,27(25):3567~3570.